John P. Hamill is SVP & CFO of WINDTREE THERAPEUTICS INC . Currently has a direct ownership of 72,800 shares of WINT, which is worth approximately $50,960. The most recent transaction as insider was on Jul 26, 2022, when has been sold 3,000 shares (Common Stock) at a price of $0.37 per share, resulting in proceeds of $1,110. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 72.8K
0% 3M change
0% 12M change
Total Value Held $50,960

John P. Hamill Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 26 2022
BUY
Open market or private purchase
$1,110 $0.37 p/Share
3,000 Added 3.96%
72,800 Common Stock
Mar 04 2022
BUY
Grant, award, or other acquisition
-
66,300 Added 48.71%
69,800 Common Stock
Apr 16 2021
BUY
Open market or private purchase
$2,070 $2.07 p/Share
1,000 Added 22.22%
3,500 Common Stock
Mar 25 2021
BUY
Open market or private purchase
$4,875 $3.25 p/Share
1,500 Added 37.5%
2,500 Common Stock
Oct 07 2020
BUY
Open market or private purchase
$5,270 $5.27 p/Share
1,000 Added 50.0%
1,000 Common Stock

Also insider at

APRE
Aprea Therapeutics, Inc. Healthcare
JPH

John P. Hamill

SVP & CFO
Warrington, PA

Track Institutional and Insider Activities on WINT

Follow WINDTREE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WINT shares.

Notify only if

Insider Trading

Get notified when an Windtree Therapeutics Inc insider buys or sells WINT shares.

Notify only if

News

Receive news related to WINDTREE THERAPEUTICS INC

Track Activities on WINT